Ladenburg Thalmann Financial Services’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History
Bought
Maintained
Sold
Other funds holding TARO
KAM
Ladenburg Thalmann Financial Services's TARO Position: Q4 2019 in Review
Ladenburg Thalmann Financial Services reduced its Taro Pharmaceutical Industries Ltd. (TARO) stake by 7.3% in Q4 2019, selling an estimated $590 and leaving 89 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #5546.
Ladenburg Thalmann Financial Services first reported a position in TARO in Q3 2014 and has held it in 22 quarters since. The position peaked at $88K in Q4 2016. 94 funds tracked by Wall St. Rank hold TARO as of Q4 2019.
- Ladenburg Thalmann Financial Services held 89 shares of Taro Pharmaceutical Industries Ltd. worth $0 as of Q4 2019.
- Ladenburg Thalmann Financial Services sold 7 Taro Pharmaceutical Industries Ltd. shares in Q4 2019, an estimated $590.
- Taro Pharmaceutical Industries Ltd. made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #5546 holding.
- Ladenburg Thalmann Financial Services first reported a position in Taro Pharmaceutical Industries Ltd. in Q3 2014 and has held it in 22 quarters since.
- Ladenburg Thalmann Financial Services's Taro Pharmaceutical Industries Ltd. position peaked at $88K in Q4 2016.
- 94 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q4 2019.
Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.